Evidence map›Paper›PMID 26108786›Full record

ArticleThe Journal of physiology2015

Osmosensation in TRPV2 dominant negative expressing skeletal muscle fibres.

Nadège Zanou, Ludivine Mondin, Clarisse Fuster, François Seghers, Inès Dufour, Marie de Clippele, Olivier Schakman, Nicolas Tajeddine, Yuko Iwata, Shigeo Wakabayashi and 3 more

Abstract read
In one paragraph

Article in The Journal of physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Lysophosphatidylcholine sensitizes TRPV2 by indirect mechanisms.Pflugers Archiv : European journal of physiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Acute RyR1 CaNature communications · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Cryo-electron microscopy structure of the TRPV2 ion channel.Nature structural & molecular biology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nadège ZanouLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.
Ludivine MondinLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.
Clarisse FusterCentre de Génétique et de Physiologie Cellulaire et Moléculaire, Université Claude Bernard Lyon 1, CNRS, UMR 5534, 69622, Villeurbanne, France.
François SeghersLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.
Inès DufourLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.
Marie de ClippeleLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.
Olivier SchakmanLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.
Nicolas TajeddineLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.
Yuko IwataDepartment of Molecular Physiology, National Cardiovascular Center Research Institute Suita, Osaka, 565-8565, Japan.
Shigeo WakabayashiDepartment of Molecular Physiology, National Cardiovascular Center Research Institute Suita, Osaka, 565-8565, Japan.
Thomas VoetsLaboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, Katholiek Universiteit Leuven, B-3000, Leuven, Belgium.
Bruno AllardCentre de Génétique et de Physiologie Cellulaire et Moléculaire, Université Claude Bernard Lyon 1, CNRS, UMR 5534, 69622, Villeurbanne, France.
Philippe GaillyLaboratory of Cell Physiology, Institute of Neuroscience, Université catholique de Louvain, av. Mounier, B1.53.17, B-1200, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased plasma osmolarity induces intracellular water depletion and cell shrinkage (CS) followed by activation of a regulatory volume increase (RVI). In skeletal muscle, the hyperosmotic shock-induced CS is accompanied by a small membrane depolarization responsible for a release of Ca(2+) from intracellular pools. Hyperosmotic shock also induces phosphorylation of STE20/SPS1-related proline/alanine-rich kinase (SPAK). TRPV2 dominant negative expressing fibres challenged with hyperosmotic shock present a slower membrane depolarization, a diminished Ca(2+) response, a smaller RVI response, a decrease in SPAK phosphorylation and defective muscle function. We suggest that hyperosmotic shock induces TRPV2 activation, which accelerates muscle cell depolarization and allows the subsequent Ca(2+) release from the sarcoplasmic reticulum, activation of the Na(+) -K(+) -Cl(-) cotransporter by SPAK, and the RVI response. Increased plasma osmolarity induces intracellular water depletion and cell shrinkage followed by activation of a regulatory volume increase (RVI). In skeletal muscle, this is accompanied by transverse tubule (TT) dilatation and by a membrane depolarization responsible for a release of Ca(2+) from intracellular pools. We observed that both hyperosmotic shock-induced Ca(2+) transients and RVI were inhibited by Gd(3+) , ruthenium red and GsMTx4 toxin, three inhibitors of mechanosensitive ion channels. The response was also completely absent in muscle fibres overexpressing a non-permeant, dominant negative (DN) mutant of the transient receptor potential, V2 isoform (TRPV2) ion channel, suggesting the involvement of TRPV2 or of a TRP isoform susceptible to heterotetramerization with TRPV2. The release of Ca(2+) induced by hyperosmotic shock was increased by cannabidiol, an activator of TRPV2, and decreased by tranilast, an inhibitor of TRPV2, suggesting a role for the TRPV2 channel itself. Hyperosmotic shock-induced membrane depolarization was impaired in TRPV2-DN fibres, suggesting that TRPV2 activation triggers the release of Ca(2+) from the sarcoplasmic reticulum by depolarizing TTs. RVI requires the sequential activation of STE20/SPS1-related proline/alanine-rich kinase (SPAK) and NKCC1, a Na(+) -K(+) -Cl(-) cotransporter, allowing ion entry and driving osmotic water flow. In fibres overexpressing TRPV2-DN as well as in fibres in which Ca(2+) transients were abolished by the Ca(2+) chelator BAPTA, the level of P-SPAK(Ser373) in response to hyperosmotic shock was reduced, suggesting a modulation of SPAK phosphorylation by intracellular Ca(2+) . We conclude that TRPV2 is involved in osmosensation in skeletal muscle fibres, acting in concert with P-SPAK-activated NKCC1.

Indexed as

AnimalsCalciumCalcium ChannelsCell SizeMaleMice, Inbred C57BLMice, TransgenicMuscle Fibers, SkeletalOsmolar ConcentrationOsmotic PressurePhosphorylationProtein Serine-Threonine KinasesSolute Carrier Family 12, Member 2TRPV Cation ChannelsCalciumCalcium ChannelsProtein Serine-Threonine KinasesSlc12a2 protein, mouseSolute Carrier Family 12, Member 2Stk39 protein, mouseTrpv2 protein, mouseTRPV Cation Channels

Identifiers

PMID26108786
PMCPMC4575573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.